Suppr超能文献

抗体协会的抗体验证网络研讨会系列。

The Antibody Society's antibody validation webinar series.

作者信息

Voskuil Jan L A, Bandrowski Anita, Begley C Glenn, Bradbury Andrew R M, Chalmers Andrew D, Gomes Aldrin V, Hardcastle Travis, Lund-Johansen Fridtjof, Plückthun Andreas, Roncador Giovanna, Solache Alejandra, Taussig Michael J, Trimmer James S, Williams Cecilia, Goodman Simon L

机构信息

Aeonian Biotech Ltd , Marcham, UK.

Center for Research in Biological Systems, University of California , La Jolla, CA, USA.

出版信息

MAbs. 2020 Jan-Dec;12(1):1794421. doi: 10.1080/19420862.2020.1794421.

Abstract

In the wake of the reproducibility crisis and numerous discussions on how commercially available antibodies as research tool contribute to it, The Antibody Society developed a series of 10 webinars to address the issues involved. The webinars were delivered by speakers with both academic and commercial backgrounds. This report highlights the problems, and offers solutions to help the scientific community appropriately identify the right antibodies and to validate them for their research and development projects. Despite the various solutions proposed here, they must be applied on a case-by-case basis. Each antibody must be verified based on the content of the product sheet, and subsequently through experimentation to confirm integrity, specificity and selectivity. Verification needs to focus on the precise application and tissue/cell type for which the antibody will be used, and all verification data must be reported openly. The various approaches discussed here all have caveats, so a combination of solutions must be considered.

摘要

在可重复性危机以及众多关于市售抗体作为研究工具如何导致这一危机的讨论之后,抗体协会举办了一系列10场网络研讨会来解决其中涉及的问题。这些网络研讨会由具有学术和商业背景的演讲者进行。本报告突出了问题,并提供了解决方案,以帮助科学界正确识别合适的抗体,并为其研发项目验证这些抗体。尽管这里提出了各种解决方案,但必须根据具体情况逐一应用。每种抗体都必须根据产品说明书的内容进行验证,随后通过实验来确认其完整性、特异性和选择性。验证需要关注抗体将用于的精确应用以及组织/细胞类型,并且所有验证数据都必须公开报告。这里讨论的各种方法都有局限性,因此必须考虑多种解决方案的组合。

相似文献

1
The Antibody Society's antibody validation webinar series.
MAbs. 2020 Jan-Dec;12(1):1794421. doi: 10.1080/19420862.2020.1794421.
2
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
MAbs. 2016 Nov/Dec;8(8):1425-1434. doi: 10.1080/19420862.2016.1227665. Epub 2016 Aug 24.
4
7
Enhanced validation of antibodies for research applications.
Nat Commun. 2018 Oct 8;9(1):4130. doi: 10.1038/s41467-018-06642-y.
8
Antibodies That Work Again and Again and Again.
Methods Mol Biol. 2017;1554:41-59. doi: 10.1007/978-1-4939-6759-9_2.
10
Humanization and Simultaneous Optimization of Monoclonal Antibody.
Methods Mol Biol. 2019;1904:213-230. doi: 10.1007/978-1-4939-8958-4_9.

引用本文的文献

1
Immunoelectron microscopy: a comprehensive guide from sample preparation to high-resolution imaging.
Discov Nano. 2025 Sep 8;20(1):154. doi: 10.1186/s11671-025-04346-z.
2
SUMO Antibody Validation.
Methods Mol Biol. 2025;2957:17-30. doi: 10.1007/978-1-0716-4710-3_2.
3
A consensus platform for antibody characterization.
Nat Protoc. 2024 Dec 17. doi: 10.1038/s41596-024-01095-8.
5
Structural, Biophysical, and Computational Studies of a Murine Light Chain Dimer.
Molecules. 2024 Jun 18;29(12):2885. doi: 10.3390/molecules29122885.
7
Can antibodies be "vegan"? A guide through the maze of today's antibody generation methods.
MAbs. 2024 Jan-Dec;16(1):2343499. doi: 10.1080/19420862.2024.2343499. Epub 2024 Apr 18.
10
YCharOS open antibody characterisation data: Lessons learned and progress made.
F1000Res. 2023 Oct 16;12:1344. doi: 10.12688/f1000research.141719.1. eCollection 2023.

本文引用的文献

1
The Rigor and Transparency Index Quality Metric for Assessing Biological and Medical Science Methods.
iScience. 2020 Oct 20;23(11):101698. doi: 10.1016/j.isci.2020.101698. eCollection 2020 Nov 20.
2
The 3rd Antibody Validation meeting: Bath UK 20-21 September 2018.
F1000Res. 2018 Dec 31;7:1989. doi: 10.12688/f1000research.17645.1. eCollection 2018.
3
High-resolution antibody array analysis of proteins from primary human keratinocytes and leukocytes.
PLoS One. 2018 Dec 27;13(12):e0209271. doi: 10.1371/journal.pone.0209271. eCollection 2018.
4
In Aptamers They Trust: The Caveats of the SOMAscan Biomarker Discovery Platform from SomaLogic.
Circulation. 2018 Nov 27;138(22):2482-2485. doi: 10.1161/CIRCULATIONAHA.118.036823. Epub 2018 Nov 26.
5
A high-throughput pipeline for validation of antibodies.
Nat Methods. 2018 Nov;15(11):909-912. doi: 10.1038/s41592-018-0179-8. Epub 2018 Oct 30.
6
Antibody validation: a view from the mountains.
N Biotechnol. 2018 Oct 25;45:1-8. doi: 10.1016/j.nbt.2018.08.002. Epub 2018 Aug 4.
7
A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors.
Nat Methods. 2018 May;15(5):330-338. doi: 10.1038/nmeth.4632. Epub 2018 Mar 19.
8
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions.
MAbs. 2018 May/Jun;10(4):539-546. doi: 10.1080/19420862.2018.1445456. Epub 2018 Mar 29.
9
Faster, deeper, smaller-the rise of antibody-like scaffolds.
Nat Biotechnol. 2017 Jul 12;35(7):602-603. doi: 10.1038/nbt0717-602.
10
Insufficient antibody validation challenges oestrogen receptor beta research.
Nat Commun. 2017 Jun 15;8:15840. doi: 10.1038/ncomms15840.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验